Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopinavir/Ritonavir vs Hydroxychloroquine in Mild COVID-19
NCT04307693Phase 2Terminated
- Sponsor
- Asan Medical Center
- Start
- Mar 2020
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lopinavir + ritonavir, hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Asan Medical Center. Started Mar 2020; status: terminated.
02
Drugs
lopinavir + ritonavirhydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04307693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04307693.